Skip to main content

Table 2 Association of lncRNA RGMB-AS1 and RGMB expression with clinicopathologic features of NSCLC patients

From: Study on expression of lncRNA RGMB-AS1 and repulsive guidance molecule b in non-small cell lung cancer

Clinicopathological factor

n

LncRNA RGMB-AS1 expression(2–ΔCt)

RGMB mRNA expression(2–ΔCt)

  

Median ± SD

P

Media ± SD

P

Gender

     

Male

47

0.0734 ± 0.0641

0.847

0.4148 ± 0.2016

0.301

Female

25

0.0763 ± 0.0557

 

0.3656 ± 0.1684

 

Age(years)

     

≥60

28

0.0634 ± 0.0638

0.226

0.4320 ± 0.2111

0.227

<60

44

0.0814 ± 0.0587

 

0.3759 ± 0.1761

 

Histology

     

SCC

44

0.0718 ± 0.0584

0.662

0.4020 ± 0.1989

0.812

Adeno

28

00784 ± 0.0656

 

0.3909 ± 0.1813

 

Differentiation

     

Well

16

0.0269 ± 0.0323

0.007*

0.5292 ± 0.1771

0.032*

Moderate

39

0.0556 ± 0.0378

 

0.4299 ± 0.1633

 

Poor

17

0.1622 ± 0.0281

 

0.2000 ± 0.0883

 

Lymphnode metastasis

     

Positive

37

0.1146 ± 0.0514

0.000*

0.3169 ± 0.1640

0.000*

Negative

35

0.0319 ± 0.0367

 

0.4832 ± 0.1819

 

TNM

     

I + II

31

0.0265 ± 0.0326

0.000*

0.5068 ± 0.1751

0.007*

III + IV

41

0.1106 ± 0.0517

 

0.3152 ± 0.1598

 
  1. SCC: Squamous cell carcinoma; Adeno: Adenocarcinoma
  2. *Indicated statistical significance (P < 0.05)